Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee C Claridge

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Hepatology (Baltimore, Md.)|March 2, 2011
Detection of acetaminophen-cysteine adducts in cases of indeterminate liver failure is not diagnostic of intentional overdoseLee C Claridge
BMJ (Clinical Research Ed.)|December 1, 2011
Barium enema and diagnosis of colorectal cancerLee C Claridge
Lancet (London, England)|June 28, 2011
Rising liver death rate: food for thoughtLee C Claridge
Lancet (London, England)|February 15, 2011
Drugs and harm to societyLee C Claridge
BMJ (Clinical Research Ed.)|April 22, 2011
Gilbert's syndromeLee C Claridge, Matthew J Armstrong, Caroline Booth, et al.
BMJ (Clinical Research Ed.)|December 4, 2010
Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adultsLee C Claridge, Bertus Eksteen, Amanda Smith, et al.
Digestive Diseases and Sciences|June 4, 2019
Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic SteatohepatitisPaul Manka, Lars Bechmann, Jan Best, et al.
Clinical Science (London, England : 1979)|January 21, 2014
Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replicationSteve S Choi, Lee C Claridge, Ravi Jhaveri, et al.
The Journal of Clinical Investigation|January 7, 2015
Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosisChris J Weston, Emma L Shepherd, Lee C Claridge, et al.
Biochimica Et Biophysica Acta|November 4, 2015
Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosisJason D Coombes, Steve S Choi, Marzena Swiderska-Syn, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Hepatology (Baltimore, Md.)|March 2, 2011
Detection of acetaminophen-cysteine adducts in cases of indeterminate liver failure is not diagnostic of intentional overdoseLee C Claridge
BMJ (Clinical Research Ed.)|December 1, 2011
Barium enema and diagnosis of colorectal cancerLee C Claridge
Lancet (London, England)|June 28, 2011
Rising liver death rate: food for thoughtLee C Claridge
Lancet (London, England)|February 15, 2011
Drugs and harm to societyLee C Claridge
BMJ (Clinical Research Ed.)|April 22, 2011
Gilbert's syndromeLee C Claridge, Matthew J Armstrong, Caroline Booth, et al.
BMJ (Clinical Research Ed.)|December 4, 2010
Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adultsLee C Claridge, Bertus Eksteen, Amanda Smith, et al.
Digestive Diseases and Sciences|June 4, 2019
Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic SteatohepatitisPaul Manka, Lars Bechmann, Jan Best, et al.
Clinical Science (London, England : 1979)|January 21, 2014
Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replicationSteve S Choi, Lee C Claridge, Ravi Jhaveri, et al.
The Journal of Clinical Investigation|January 7, 2015
Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosisChris J Weston, Emma L Shepherd, Lee C Claridge, et al.
Biochimica Et Biophysica Acta|November 4, 2015
Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosisJason D Coombes, Steve S Choi, Marzena Swiderska-Syn, et al.
Pageof 2